November 2020

La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases

IDIBELL has been one of the institutions with more funded projects, up to 10, of which it leads 7, and participates in 3 more projects as a collaborator.

New biomedical breakthroughs of Bellvitge, live streaming on November 28th

Next Saturday, November 28th, researchers of Bellvitge will present their most recent investigations to the general public. The new website Sinergia will broadcast a wide program of virtual talks. Sinergia has been specifically released to celebrate the first virtual edition of the Festival for the Research and Innovation in Health of L’Hospitalet.

The combination of two immunomodulatory drugs could be beneficial for more severe Covid-19 patients

A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital (HUB) sign an article in the International Journal of Infectious Diseases, where they demonstrate the beneficial effect of the use of corticosteroids added to tocilizumab treatment to improve the prognosis of critical patients of Covid-19.

Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs

The Intensive Medicine Service of the Bellvitge University Hospital (HUB) participates, through the Bellvitge Biomedical Research Institute (IDIBELL), in the European ENVISION project, which will develop an intelligent decision support system to improve the monitoring and treatment of patients with Covid-19 in ICUs.

The impact of the pandemic on people with eating disorders and obesity

Dr. Fernando Fernández-Aranda is currently the editor-in-chief of the European Eating Disorders Review, a journal that has published a special issue in October focusing on the impact of the pandemic and lockdown on patients with eating disorders and obesity. We spoke with Dr. Fernández-Aranda about this special and the reflections they have extracted.

Scroll to Top